|
Age (> 60 years)
|
0.63 (0.16–2.41)
|
0.50
| | |
|
Sex (Female)
|
0.70 (0.16–2.98)
|
0.63
| | |
|
Staging of hepatic fibrosis (Stage 4)
|
1.44 (0.38–5.57)
|
0.59
| | |
|
AFP (> 8.7 ng/ml)
|
2.67 (0.65–10.88)
|
0.17
| | |
|
PIVKA-II (> 40 mAU/mL)
|
4.38 (1.03–18.63)
|
0.05
|
2.71 (0.47–15.58)
|
0.26
|
|
Edmondson-Steiner grade of HCC (III)
|
4.75 (0.95–23.85)
|
0.06
|
5.64 (0.67–47.25)
|
0.11
|
|
Total volume of HCC (> 4.5 ml)
|
2.16 (0.54–8.57)
|
0.27
| | |
|
Maximal diameter of HCC (> 32 mm)
|
4.53 (1.06–19.41)
|
0.04
|
4.04 (0.67–24.37)
|
0.13
|
|
Peritumoral enhancement
|
3.15 (0.78–12.73)
|
0.11
| | |
|
Nonsmooth tumor margin
|
3.00 (0.72–12.55)
|
0.13
| | |
|
NIC of outer layer 1 (> 0.082 mg/ml)
|
6.42 (1.37–30.05)
|
0.02
|
7.14 (1.12–45.40)
|
0.04
|